Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus. A Multicenter Two-armed Cluster-randomized Controlled Trial

NCT05714930 is registered in ClinicalTrials.gov with Heinrich-Heine University, Duesseldorf as lead sponsor.

NCT NCT05714930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05714930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus. A Multicenter Two-armed Cluster-randomized Controlled Trial
Lead sponsor
Heinrich-Heine University, Duesseldorf
Phase
Not applicable
Overall status
Recruiting
Start date
December 12, 2023
Completion date
March 31, 2030
Enrollment
606 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus